ダウンロード数: 3797
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
JMCC2003_Yoshida.pdf | 394.59 kB | Adobe PDF | 見る/開く |
タイトル: | iPS cells: A source of cardiac regeneration |
著者: | Yoshida, Yoshinori https://orcid.org/0000-0001-5511-9090 (unconfirmed) Yamanaka, Shinya |
著者名の別形: | 吉田, 善紀 山中, 伸弥 |
キーワード: | iPS cells Reprogramming |
発行日: | Feb-2011 |
出版者: | Elsevier |
誌名: | Journal of Molecular and Cellular Cardiology |
巻: | 50 |
号: | 2 |
開始ページ: | 327 |
終了ページ: | 332 |
抄録: | For the treatment of heart failure, a new strategy to improve cardiac function and inhibit cardiac remodeling needs to be established. Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) are pluripotent cells that can differentiate into cell types from all three germ layers both in vitro and in vivo. The therapeutic effect of ES/iPS cell-derived progeny was reported in animal model. Mouse and human somatic cells can be reprogrammed to induced pluripotent stem cells (iPSCs) by the transduction of four transcription factors, Oct 3/4, Sox2, Klf4, and c-Myc. However, the low induction efficiency hinders the clinical application of iPS technology, and efforts have been made to improve the reprogramming efficiency. There are variations in the characteristics in ES/iPS cell lines, and the further understanding is necessary for the applications of ES/iPS cell technology. Some improvements were also made in the methods to induce cardiomyocytes from ES/iPS cells efficiently. This review article is focused on generation of iPS cells, cardiomyocyte differentiation from ES/iPS cells, and transplantation of derived cardiomyocytes.This article is part of a special issue entitled, "Cardiovascular Stem Cells Revisited". |
著作権等: | © 2010 Elsevier Ltd This is not the published version. Please cite only the published version. この論文は出版社版でありません。引用の際には出版社版をご確認ご利用ください。 |
URI: | http://hdl.handle.net/2433/139198 |
DOI(出版社版): | 10.1016/j.yjmcc.2010.10.026 |
PubMed ID: | 21040726 |
出現コレクション: | 学術雑誌掲載論文等 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。